FORMULATIONS TRANSDERMIQUES POUR L'ADMINISTRATION DE CELECOXIB ET LEUR UTILISATION DANS LE TRAITEMENT DE MALADIES ET DE PATHOLOGIES SENSIBLES AU CELCOXIB
The present application is directed to transdermal formulations for the delivery of celecoxib to a subject for the treatment of celecoxib-responsive diseases or conditions. In particular, the transdermal formulation is an emulsion comprising an oil phase, an aqueous phase and an external phase.